| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Cannabidiol | Acute Liver Failure | 1 | PM | 21182490 | 📋 | Cannabidiol Improves Brain and Liver Function in a Fulminant Hepatic Failure-Induced Model of Hepatic Encephalopathy in Mice |
| Cannabidiol | Anorexia Nervosa | 1 | PM | 9309469 | 📋 | Effects of Dronabinol on Anorexia and Disturbed Behavior in Patients With Alzheimer's Disease |
| Cannabidiol | Autoimmune Hepatitis | 1 | PM | 19647124 | 📋 | Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis |
| Cannabidiol | Biliary Tract Cancer | 2 | PM | 35740979 | 📋 | Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways |
| Cannabidiol | Biliary Tract Cancer | 1 | PM | 19916793 | 📋 | The Dual Effects of delta(9)-tetrahydrocannabinol on Cholangiocarcinoma Cells: Anti-Invasion Activity at Low Concentration and Apoptosis Induction at High Concentration |
| Cannabidiol | Colitis | 10 | PM | 38175840 | 📋 | Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice |
| Cannabidiol | Colitis | 9 | PM | 33331878 | 📋 | Cannabinoid receptor activation on hematopoietic cells and enterocytes protects against colitis |
| Cannabidiol | Colitis | 8 | PM | 33162890 | 📋 | Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis |
| Cannabidiol | Colitis | 1 | PM | 27757083 | 📋 | An Orally Active Cannabis Extract With High Content in Cannabidiol Attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse |
| Cannabidiol | Colitis | 2 | PM | 23415610 | 📋 | Beneficial Effect of the Non-Psychotropic Plant Cannabinoid Cannabigerol on Experimental Inflammatory Bowel Disease |
| Cannabidiol | Colitis | 7 | PM | 23373571 | 📋 | The Cannabinoid TRPA1 Agonist Cannabichromene Inhibits Nitric Oxide Production in Macrophages and Ameliorates Murine Colitis |
| Cannabidiol | Colitis | 6 | PM | 22965195 | 📋 | O-1602, an Atypical Cannabinoid, Inhibits Tumor Growth in Colitis-Associated Colon Cancer Through Multiple Mechanisms |
| Cannabidiol | Colitis | 4 | PM | 21744421 | 📋 | The Atypical Cannabinoid O-1602 Protects Against Experimental Colitis and Inhibits Neutrophil Recruitment |
| Cannabidiol | Colitis | 5 | PM | 20590574 | 📋 | The Effects of Delta-tetrahydrocannabinol and Cannabidiol Alone and in Combination on Damage, Inflammation and in Vitro Motility Disturbances in Rat Colitis |
| Cannabidiol | Colitis | 3 | PM | 19690824 | 📋 | Cannabidiol, a Safe and Non-Psychotropic Ingredient of the Marijuana Plant Cannabis Sativa, Is Protective in a Murine Model of Colitis |
| Cannabidiol | Colon Cancer | 6 | PM | 37577382 | 📋 | Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer |
| Cannabidiol | Colon Cancer | 4 | PM | 30076849 | 📋 | Cannabinoid Pharmacology and Therapy in Gut Disorders |
| Cannabidiol | Colon Cancer | 2 | PM | 25269802 | 📋 | Colon Carcinogenesis Is Inhibited by the TRPM8 Antagonist Cannabigerol, a Cannabis-derived Non-Psychotropic Cannabinoid |
| Cannabidiol | Colon Cancer | 3 | PM | 22965195 | 📋 | O-1602, an Atypical Cannabinoid, Inhibits Tumor Growth in Colitis-Associated Colon Cancer Through Multiple Mechanisms |
| Cannabidiol | Colon Cancer | 1 | PM | 22231745 | 📋 | Chemopreventive Effect of the Non-Psychotropic Phytocannabinoid Cannabidiol on Experimental Colon Cancer |
| Cannabidiol | Colon Cancer | 5 | PM | 22110202 | 📋 | Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent |
| Cannabidiol | Colorectal Cancer | 11 | PM | 38358093 | 📋 | Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells |
| Cannabidiol | Colorectal Cancer | 10 | PM | 35960375 | 📋 | Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway |
| Cannabidiol | Colorectal Cancer | 9 | PM | 35598400 | 📋 | Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells |
| Cannabidiol | Colorectal Cancer | 7 | PM | 32765628 | 📋 | Cannabinoid Effects on Experimental Colorectal Cancer Models Reduce Aberrant Crypt Foci (ACF) and Tumor Volume: A Systematic Review |
| Cannabidiol | Colorectal Cancer | 6 | PM | 32752303 | 📋 | Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83 |
| Cannabidiol | Colorectal Cancer | 8 | PM | 32294046 | 📋 | Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol |
| Cannabidiol | Colorectal Cancer | 3 | PM | 31195721 | 📋 | Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- And SOD2-Induced Autophagy in Human Colorectal Cancer Cells |
| Cannabidiol | Colorectal Cancer | 2 | PM | 31075907 | 📋 | Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer |
| Cannabidiol | Colorectal Cancer | 1 | PM | 30660647 | 📋 | Cannabidiol-induced Apoptosis Is Mediated by Activation of Noxa in Human Colorectal Cancer Cells |
| Cannabidiol | Colorectal Cancer | 4 | PM | 17583570 | 📋 | The Cannabinoid delta(9)-tetrahydrocannabinol Inhibits RAS-MAPK and PI3K-AKT Survival Signalling and Induces BAD-mediated Apoptosis in Colorectal Cancer Cells |
| Cannabidiol | Colorectal Cancer | 5 | PM | 17237277 | 📋 | HU-331, a Novel Cannabinoid-Based Anticancer Topoisomerase II Inhibitor |
| Cannabidiol | Gastric Cancer | 3 | PM | 31699976 | 📋 | Cannabidiol Promotes Apoptosis via Regulation of XIAP/Smac in Gastric Cancer |
| Cannabidiol | Gastric Cancer | 2 | PM | 31349651 | 📋 | Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells |
| Cannabidiol | Gastric Cancer | 1 | PM | 19394652 | 📋 | Pharmacological Synergism Between Cannabinoids and Paclitaxel in Gastric Cancer Cell Lines |
| Cannabidiol | Gastrointestinal Disorders | 1 | PM | 26408170 | 📋 | Endocannabinoids and the Digestive Tract and Bladder in Health and Disease |
| Cannabidiol | Hepatic Cirrhosis | 1 | PM | 29890719 | 📋 | The Role of Cannabinoids in the Setting of Cirrhosis |
| Cannabidiol | Hepatic Encephalopathy | 1 | PM | 21182490 | 📋 | Cannabidiol Improves Brain and Liver Function in a Fulminant Hepatic Failure-Induced Model of Hepatic Encephalopathy in Mice |
| Cannabidiol | Hepatic Fibrosis | 2 | PM | 38711461 | 📋 | Cannabidiol alleviates carbon tetrachloride-induced liver fibrosis in mice by regulating NF-κB and PPAR-α pathways |
| Cannabidiol | Hepatic Fibrosis | 1 | PM | 21654828 | 📋 | Cannabidiol Causes Activated Hepatic Stellate Cell Death Through a Mechanism of Endoplasmic Reticulum Stress-Induced Apoptosis |
| Cannabidiol | Hepatic Ischemia-Reperfusion | 1 | PM | 21930120 | 📋 | Therapeutic Potential of Cannabidiol Against ischemia/reperfusion Liver Injury in Rats |
| Cannabidiol | Hepatitis C | 1 | PM | 28250664 | 📋 | Potential of Cannabidiol for the Treatment of Viral Hepatitis |
| Cannabidiol | Inflammatory Bowel Disease | 16 | PM | 38175840 | 📋 | Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice |
| Cannabidiol | Inflammatory Bowel Disease | 15 | PM | 32996187 | 📋 | Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation |
| Cannabidiol | Inflammatory Bowel Disease | 12 | PM | 32357565 | 📋 | Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals? |
| Cannabidiol | Inflammatory Bowel Disease | 10 | PM | 30076849 | 📋 | Cannabinoid Pharmacology and Therapy in Gut Disorders |
| Cannabidiol | Inflammatory Bowel Disease | 2 | PM | 29082314 | 📋 | Anti-Inflammatory Activity in Colon Models Is Derived From Δ9-Tetrahydrocannabinolic Acid That Interacts With Additional Compounds in Cannabis Extracts |
| Cannabidiol | Inflammatory Bowel Disease | 3 | PM | 28954820 | 📋 | Cannabidiol and Palmitoylethanolamide Are Anti-Inflammatory in the Acutely Inflamed Human Colon |
| Cannabidiol | Inflammatory Bowel Disease | 13 | PM | 28276820 | 📋 | Cannabinoids for Treating Inflammatory Bowel Diseases: Where Are We and Where Do We Go? |
| Cannabidiol | Inflammatory Bowel Disease | 5 | PM | 27757083 | 📋 | An Orally Active Cannabis Extract With High Content in Cannabidiol Attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse |
| Cannabidiol | Inflammatory Bowel Disease | 14 | PM | 24969296 | 📋 | Cannabis for Inflammatory Bowel Disease |
| Cannabidiol | Inflammatory Bowel Disease | 1 | PM | 23648372 | 📋 | Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study |
| Cannabidiol | Inflammatory Bowel Disease | 6 | PM | 23415610 | 📋 | Beneficial Effect of the Non-Psychotropic Plant Cannabinoid Cannabigerol on Experimental Inflammatory Bowel Disease |
| Cannabidiol | Inflammatory Bowel Disease | 11 | PM | 23373571 | 📋 | The Cannabinoid TRPA1 Agonist Cannabichromene Inhibits Nitric Oxide Production in Macrophages and Ameliorates Murine Colitis |
| Cannabidiol | Inflammatory Bowel Disease | 4 | PM | 22163000 | 📋 | Cannabidiol Reduces Intestinal Inflammation Through the Control of Neuroimmune Axis |
| Cannabidiol | Inflammatory Bowel Disease | 8 | PM | 21744421 | 📋 | The Atypical Cannabinoid O-1602 Protects Against Experimental Colitis and Inhibits Neutrophil Recruitment |
| Cannabidiol | Inflammatory Bowel Disease | 9 | PM | 20590574 | 📋 | The Effects of Delta-tetrahydrocannabinol and Cannabidiol Alone and in Combination on Damage, Inflammation and in Vitro Motility Disturbances in Rat Colitis |
| Cannabidiol | Inflammatory Bowel Disease | 7 | PM | 18469842 | 📋 | Cannabidiol, Extracted From Cannabis Sativa, Selectively Inhibits Inflammatory Hypermotility in Mice |
| Cannabidiol | Intestinal Permeability | 1 | PM | 20592049 | 📋 | Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability |
| Cannabidiol | Irritable Bowel Syndrome | 2 | PM | 32357565 | 📋 | Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals? |
| Cannabidiol | Irritable Bowel Syndrome | 1 | PM | 30076849 | 📋 | Cannabinoid Pharmacology and Therapy in Gut Disorders |
| Cannabidiol | Liver Cancer | 4 | PM | 38825256 | 📋 | Cannabidiol reverts the malignant phenotype of hepatocellular carcinoma cells via the GPR55/TP53/MAPK axis |
| Cannabidiol | Liver Cancer | 3 | PM | 37568803 | 📋 | Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma |
| Cannabidiol | Liver Cancer | 2 | PM | 34350183 | 📋 | A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis |
| Cannabidiol | Liver Cancer | 1 | PM | 21475304 | 📋 | Anti-tumoral Action of Cannabinoids on Hepatocellular Carcinoma: Role of AMPK-dependent Activation of Autophagy |
| Cannabidiol | Liver Damage | 1 | PM | 21930120 | 📋 | Therapeutic Potential of Cannabidiol Against ischemia/reperfusion Liver Injury in Rats |
| Cannabidiol | Liver Disease | 1 | PM | 38397045 | 📋 | The Role of Cannabidiol in Liver Disease: A Systemic Review |
| Cannabidiol | MAFLD | 1 | PM | 28441459 | 📋 | Cannabis Use Is Associated With Reduced Prevalence of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study |
| Cannabidiol | MAFLD | 2 | PM | 25595882 | 📋 | Two Non-Psychoactive Cannabinoids Reduce Intracellular Lipid Levels and Inhibit Hepatosteatosis |
| Cannabidiol | Non-Alcoholic Steatohepatitis | 1 | PM | 31032942 | 📋 | Cannabidiol Protects Livers Against Nonalcoholic Steatohepatitis Induced by High-Fat High Cholesterol Diet via Regulating NF-κB and NLRP3 Inflammasome Pathway |
| Cannabidiol | Oral and Dental Health | 3 | PM | 38788594 | 📋 | Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects |
| Cannabidiol | Oral and Dental Health | 2 | PM | 37298644 | 📋 | Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry |
| Cannabidiol | Oral and Dental Health | 1 | PM | 34562980 | 📋 | The Current and Potential Application of Medicinal Cannabis Products in Dentistry |
| Cannabidiol | Oral Cancer | 2 | PM | 36555480 | 📋 | Real-Time Monitoring of the Cytotoxic and Antimetastatic Properties of Cannabidiol in Human Oral Squamous Cell Carcinoma Cells Using Electric Cell-Substrate Impedance Sensing |
| Cannabidiol | Oral Cancer | 1 | PM | 20516734 | 📋 | Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells |
| Cannabidiol | Oral Candidiasis | 1 | PM | 36015249 | 📋 | Potential Combinatory Effect of Cannabidiol and Triclosan Incorporated into Sustained Release Delivery System against Oral Candidiasis |
| Cannabidiol | Oral Mucositis | 3 | PM | 35669853 | 📋 | Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways |
| Cannabidiol | Oral Mucositis | 1 | PM | 32400905 | 📋 | Cannabidiol on 5-FU-induced Oral Mucositis in Mice |
| Cannabidiol | Oral Mucositis | 2 | PM | 28191662 | 📋 | Cannabidiol: An Alternative Therapeutic Agent for Oral Mucositis? |
| Cannabidiol | Pancreatic Cancer | 5 | PM | 35409142 | 📋 | A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells |
| Cannabidiol | Pancreatic Cancer | 4 | PM | 33126623 | 📋 | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
| Cannabidiol | Pancreatic Cancer | 3 | PM | 32992648 | 📋 | Cannabidiol and Oxygen-Ozone Combination Induce Cytotoxicity in Human Pancreatic Ductal Adenocarcinoma Cell Lines |
| Cannabidiol | Pancreatic Cancer | 1 | PM | 30706048 | 📋 | Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer |
| Cannabidiol | Pancreatic Cancer | 2 | PM | 16500647 | 📋 | Cannabinoid Derivatives Induce Cell Death in Pancreatic MIA PaCa-2 Cells via a Receptor-Independent Mechanism |
| Cannabidiol | Pancreatitis | 2 | PM | 37903028 | 📋 | Cannabidiol Mitigates Lipopolysaccharide-Induced Pancreatic Pathology: A Promising Therapeutic Strategy |
| Cannabidiol | Pancreatitis | 1 | PM | 28174520 | 📋 | Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids |
| Cannabidiol | Scleroderma | 1 | PM | 36537770 | 📋 | Topical Cannabidiol in the Treatment of Digital Ulcers in Patients with Scleroderma: Comparative Analysis and Literature Review |
| Cannabidiol | Ulcerative Colitis | 1 | PM | 29538683 | 📋 | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis |
| Cannabidiol | Ulcerative Colitis | 2 | PM | 22163000 | 📋 | Cannabidiol Reduces Intestinal Inflammation Through the Control of Neuroimmune Axis |
| Cannabidiol | Vomiting | 1 | PM | 26030435 | 📋 | Synergy Between Cannabidiol, Cannabidiolic Acid, and Δ⁹-tetrahydrocannabinol in the Regulation of Emesis in the Suncus Murinus (House Musk Shrew) |
